Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-23

Clinical Trial Update: Psyllium in Pediatric IBS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating psyllium for pediatric irritable bowel syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psyllium (psyllium)

Snippet

Sponsor: Dr Bruno Chumpitazi, M.D. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: RECRUITING